A randomized, multicenter, parallel-group, Phase III study to compare the efficacy of arfolitixorin versus leucovorin in combination with 5 fluorouracil, oxaliplatin, and bevacizumab in patients with advanced colorectal cancer.
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Primary objectives: Overall response rate (ORR) Primary endpoints: Best ORR, defined as the best response recorded from the start of the study treatment until the end of treatment.
创建时间：
2018-11-15
